Lepore Patrick G Insider Trades

Insider Trading History

Track insider trading activity for Lepore Patrick G. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.6k 20,000 shares
$0.38
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $34.2k 51,472 shares
Last Trade
Jan 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$43.8k 15,000 shares
$2.92
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48k 20,000 shares
$2.40
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.6k 20,000 shares
$2.33
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54k 20,000 shares
$2.70
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $24.3k 36,472 shares
Last Trade
Nov 15, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50.8k 13,000 shares
$3.91
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $15.6k 23,472 shares
Last Trade
Mar 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49.6k 20,000 shares
$2.48
$0.67
Lannett , Inc.
Lannett , Inc. LCI
Director
Holding Value $402k 587,145 shares
Last Trade
Nov 10, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49k 100,000 shares
$0.49
$0.69
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.6k 20,500 shares
Last Trade
Aug 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.4k 20,500 shares
$0.31
$0.67
Menlo Therapeutics
Menlo Therapeutics MNLO
Director
Holding Value $0 20,500 shares
Last Trade
Aug 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Lannett , Inc.
Lannett , Inc. LCI
Director
Holding Value $334k 487,145 shares
Last Trade
May 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27k 50,000 shares
$0.54
$0.69
Lannett , Inc.
Lannett , Inc. LCI
Director
Holding Value $300k 437,145 shares
Last Trade
Feb 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$44k 50,000 shares
$0.88
$0.69
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $41.6k 62,500 shares
Last Trade
Nov 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.8k 12,500 shares
$1.02
$0.67
Lannett , Inc.
Lannett , Inc. LCI
Director
Holding Value $265k 387,145 shares
Last Trade
Nov 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$85.5k 50,000 shares
$1.71
$0.69
Lannett , Inc.
Lannett , Inc. LCI
Director
Holding Value $231k 337,145 shares
Last Trade
Sep 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$66.2k 20,000 shares
$3.31
$0.69
Lannett , Inc.
Lannett , Inc. LCI
Director
Holding Value $217k 317,145 shares
Last Trade
Aug 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 56,819 shares
$3.52
$0.69
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $33.3k 50,000 shares
Last Trade
Aug 25, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20k 12,500 shares
$1.60
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.6k 20,500 shares
Last Trade
Jul 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.4k 20,500 shares
$2.75
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $24.9k 37,500 shares
Last Trade
May 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$45k 12,500 shares
$3.60
$0.67
Lannett , Inc.
Lannett , Inc. LCI
Director
Holding Value $178k 260,326 shares
Last Trade
May 11, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$83.6k 20,000 shares
$4.18
$0.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up